Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03068351
Title Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford Cancer Center Stanford California 94305-5820 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Emory Uni - Winship Cancer Center; Hematology/Oncology Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mount Sinai - PRIME; Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
Duke Clin Rsch Institute Durham North Carolina 27710 United States Details
Scientia Clinical Research Limited Randwick New South Wales 2031 Australia Details
St Vincent's Hospital Melbourne Fitzroy Victoria 3065 Australia Details
University College London Hospitals; Clinical Research Facility London W1T 7HA United Kingdom Details
Oxford University Hospitals NHS Trust; Churchill Hospital Oxford United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field